Suppr超能文献

朝着更安全的处方开具迈进:评估韩国前瞻性药物利用审查系统对不适当处方、处方模式、药物不良事件及相关卫生支出的影响。

Toward safer prescribing: evaluation of a prospective drug utilization review system on inappropriate prescriptions, prescribing patterns, and adverse drug events and related health expenditure in South Korea.

机构信息

Department of Nursing, College of Nursing, Eulji University, Seongnam, Republic of Korea; Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea.

Institute of Health Services Research, Yonsei University, Seoul, Republic of Korea; Department of Research and analysis, National Health Insurance Service Ilsan Hospital, Ilsan, Republic of Korea.

出版信息

Public Health. 2018 Oct;163:128-136. doi: 10.1016/j.puhe.2018.06.009. Epub 2018 Aug 24.

Abstract

OBJECTIVES

This study aimed to evaluate the effect of the prospective drug utilization review (DUR) system introduced in Korea in December 2010 as a real-time method to improve patient safety, in terms of changes in prescribing practices, adverse drug events (ADEs), and ADE-related healthcare expenditure, using non-steroidal anti-inflammatory drugs (NSAIDs) and their common ADEs as a guide.

STUDY DESIGN

We used an interrupted time-series study design using generalized estimating equations to evaluate changes in prescription rate and ADE-related healthcare expenditure. Cox regression analysis was used to evaluate the probability of NSAID-associated ADEs.

METHODS

A total of 154,585 outpatients with musculoskeletal or connective tissue disorders, without pre-existing gastric bleeding or ulcers were included in this study. The primary outcome was the level and trend change in prescription rate, drug-drug interactions, coprescribed gastro-protective drugs, and defined daily dose (DDD) of NSAIDs. The secondary outcome was the probability of ADEs and changes in ADE-related healthcare expenditure.

RESULTS

There was a significant trend change after introducing the DUR system in terms of drug-drug interactions (-3.6%) and coprescribed gastro-protective drugs (+0.6%). The mean DDD of NSAIDs increased by 0.2. The probability of ADEs decreased overall (-1.7%) and in the high-risk group (age ≥65 years; -9.6%); however, only the latter was significant. There was no significant trend or level change in ADE-related health expenditure.

CONCLUSIONS

The introduction of the DUR system was associated with more efficient prescribing, including a reduction in drug-drug interactions and an increase in the use of gastro-protective drugs. The system had a positive effect on patient outcome but was not associated with reduced ADE-related costs. Further studies are needed to evaluate the long-term effects of the DUR system in Korea.

摘要

目的

本研究旨在评估 2010 年 12 月在韩国引入的前瞻性药物利用审查(DUR)系统的效果,该系统作为一种实时方法,以改善患者安全,使用非甾体抗炎药(NSAIDs)及其常见的不良反应(ADE)作为指导,评估处方实践、药物不良反应(ADE)和与 ADE 相关的医疗支出的变化。

研究设计

我们使用广义估计方程的中断时间序列研究设计来评估处方率和与 ADE 相关的医疗支出的变化。Cox 回归分析用于评估 NSAID 相关 ADE 的概率。

方法

本研究共纳入 154585 名患有肌肉骨骼或结缔组织疾病、无预先存在的胃出血或溃疡的门诊患者。主要结局是处方率、药物相互作用、联合使用胃保护药物和 NSAIDs 的定义日剂量(DDD)的水平和趋势变化。次要结局是 ADE 的概率和与 ADE 相关的医疗支出的变化。

结果

引入 DUR 系统后,药物相互作用(-3.6%)和联合使用胃保护药物(+0.6%)方面出现了显著的趋势变化。NSAIDs 的平均 DDD 增加了 0.2。总的来说,ADE 的概率降低了(-1.7%),高危组(年龄≥65 岁;-9.6%)也是如此,但只有后者有统计学意义。与 ADE 相关的医疗支出没有明显的趋势或水平变化。

结论

引入 DUR 系统与更有效的处方相关,包括减少药物相互作用和增加胃保护药物的使用。该系统对患者的结果有积极影响,但与降低与 ADE 相关的成本无关。需要进一步研究来评估韩国 DUR 系统的长期效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验